YD
Yves A. Dauvilliers
Distinguished in ADULT Syndrome

Yves A. Dauvilliers

CHU Gui De Chaulhiac
France
Distinguished
 in ADULT Syndrome
Clinical Trials:Currently Recruiting for 2 Trials
About|Expertise|Location|Research
Areas of Expertise

Many experts have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a expert treats and their level of experience.

Check Yves A. Dauvilliers' experience treating your condition:
About Yves A. Dauvilliers

Yves Dauvilliers practices in Montpellier, France. Dauvilliers is rated as a Distinguished expert by MediFind in the treatment of ADULT Syndrome. He is also highly rated in 24 other conditions, according to our data. His top areas of expertise are Excessive Daytime Sleepiness, Drowsiness, Narcolepsy, and Kleine Levin Syndrome.

His clinical research consists of co-authoring 366 peer reviewed articles and participating in 12 clinical trials in the past 15 years. In particular, he has co-authored 17 articles in the study of ADULT Syndrome.

Locations
Montpellier, 34295, FR
Background & Education
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials
Do Sleep and Circadian Rhythm Disturbances Impact the Cognitive and Behavioural Development of Children With Autism?
Enrollment Status: Recruiting
Publish Date: June 30, 2022
Intervention Type: Other
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-controlled Trial Comparing the Efficacy and Tolerance of Sodium Oxybate in Patients Affected With Idiopathic Hypersomnia
Enrollment Status: Recruiting
Publish Date: February 12, 2021
Intervention Type: Drug
Study Drug: Sodium Oxybate Oral Solution
Study Phase: Phase 2/Phase 3
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: October 10, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 10, 2022
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
Double Blind, Multicentre, Randomized, Placebo-controlled Trial to Evaluate Safety and Efficacy of Pitolisant in Children From 6 to Less Than 18 Years With Narcolepsy With/Without Cataplexy, Followed by a Prolonged Open-label Period
Enrollment Status: Active, not recruiting
Publish Date: January 14, 2022
Intervention Type: Drug
Study Drug: Pitolisant
Study Phase: Phase 3
Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness
Enrollment Status: Completed
Publish Date: December 01, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
Enrollment Status: Completed
Publish Date: November 12, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
Executive Dysfunction in Restless Legs Syndrome: Determination of Clinical Correlates and Outcome After Therapeutic Management
Enrollment Status: Unknown status
Publish Date: October 05, 2020
Intervention Type: Other
Study Phase: Not Applicable
Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients
Enrollment Status: Completed
Publish Date: September 04, 2020
Intervention Type: Drug
Study Phase: Phase 2
Self-help Program for Hypnotics Withdrawal in Chronic Insomniac Patients: A Randomized Controlled Clinical Trial
Enrollment Status: Completed
Publish Date: January 02, 2020
Intervention Type: Other, Behavioral
Study Phase: Not Applicable
Comparative Study of Efficacy of Titratable Mandibular Advancement Splint Versus Active Mandibular Advancement Splint to Treat Patients With Obstructive Sleep Apnea
Enrollment Status: Unknown status
Publish Date: May 16, 2018
Intervention Type: Device
Study Phase: Not Applicable
Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome : a Pilot Randomized, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: May 15, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 10 Less Clinical Trials -
366 Total Publications
Dissemination of circulating tumor cells at night: role of sleep or circadian rhythm?
Journal: Genome biology
Published: October 14, 2022
Save this expert for later
Sign Up
Looking for the best expert for you?
Start Here
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more